Virus-like particle display of HER2 induces potent anti-cancer responses

Virus-like particle display of HER2 induces potent anti-cancer responses

Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effects and development of resistance. Active vaccination...

Full description

Bibliographic Details
Main Authors: Arianna Palladini, Susan Thrane, Christoph M. Janitzek, Jessica Pihl, Stine B. Clemmensen, Willem Adriaan de Jongh, Thomas M. Clausen, Giordano Nicoletti, Lorena Landuzzi, Manuel L. Penichet, Tania Balboni, Marianna L. Ianzano, Veronica Giusti, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Pier-Luigi Lollini, Patrizia Nanni, Adam F. Sander
Format: Article
Language:English
Published: Taylor & Francis Group 2018-03-01
Series:OncoImmunology
Subjects:
virus-like particle
her2
vaccine
breast cancer
nano-particle
therapeutic vaccination
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1408749

Internet

http://dx.doi.org/10.1080/2162402X.2017.1408749

Similar Items